Home > Insider Trading > Filing (0001144204-13-008049)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374328	Bond Laboratories Inc.	BNLB	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341950	Vicis Capital, Llc	445 Park Avenue Suite 1043 New York NY 10022		No	No	Yes	No
1365954	Fund Master Capital Vicis	445 Park Avenue Suite 1043 New York NY 10022		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-11-06	12,606,780	$0.00	12,606,779	No	4	S	Indirect	By Vicis Capital Master Fund
Common Stock	Disposition	2012-12-28	12,606,779	$0.01	0	No	4	S	Indirect	By Vicis Capital Master Fund
10% Cumulative Perpetual Series B Preferred Stock	Disposition	2012-11-06	79	$0.00	0	No	4	S	Indirect	By Vicis Capital Master Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Vicis Capital Master Fund
No	4	S	Indirect	By Vicis Capital Master Fund
No	4	S	Indirect	By Vicis Capital Master Fund

Footnotes

Represents the indirect holdings of Vicis Capital LLC. All of the foregoing represents securities held directly by Vicis Capital Master Fund. Vicis Capital, LLC acts as investment advisor to Vicis Capital Master Fund and therefore has voting and dispositive power over all the foregoing shares. For the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Vicis Capital, LLC may be deemed to be the beneficial owner of, but hereby disclaims such beneficial ownership of, the foregoing shares.
On November 6, 2012, Vicis Capital Master Fund sold 79 shares of the Issuer's 10% Cumulative Perpetual Series B Preferred Stock and 12,606,780 of the Issuer's Common Stock in a series of privately negotiated transactions for aggregate consideration of $450,000.